To evaluate the synthetic lethality concept of ATR inhibition and ARID1A deficiency in colon cancer cell lines, the ATR inhibitor VE821 and VE822 were used to exert synergistic effects with irradiation on ARID1A- cancer cells. The gene discussed is ATR; the disease is colonic neoplasm.